Tourmaline Bio, Inc. - Common Stock, par value $0.0001 per share (TRML)

Historical Holders from Q4 2023 to Q3 2025

Symbol
TRML on Nasdaq
CUSIP
89157D105
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
25.7M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
24.1M
Holdings value
$385M
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
107
Number of buys
51
Number of sells
-49
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tourmaline Bio, Inc. - Common Stock, par value $0.0001 per share (TRML)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Avoro Capital Advisors LLC 9.95% $58.9M 2.56M Avoro Capital Advisors LLC Jun 30, 2025
QVT Financial LP 8.39% +44.2% $49.7M $15.7M 2.15M +46.2% QVT Financial LP Jun 30, 2025
Blue Owl Capital Holdings LP 4.2% $13.6M 1.08M Blue Owl Capital Holdings LP Dec 31, 2024

Institutional Holders of Tourmaline Bio, Inc. - Common Stock, par value $0.0001 per share (TRML)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 570 $27.3K +$5.79K $47.83 1
2025 Q2 24.1M $385M +$2.89M $15.99 107
2025 Q1 23.9M $364M +$11.4M $15.21 107
2024 Q4 22.9M $464M +$8.43M $20.28 100
2024 Q3 21M $541M +$2.04M $25.71 90
2024 Q2 21.2M $272M -$49.2M $12.86 83
2024 Q1 20.6M $470M +$169M $22.90 97
2023 Q4 14.5K $380K +$380K $26.18 1